1deSauvage FJ, Hass PE, Spencer SD, et al, StimuLation of megakaryocytopioesis and thrombopoisis by the c-mpl ligand.Nature 1994,369 : 533.
2Bartley TD.Bogenberger J,Huint P,et aL Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor c-mpl. Cell, 1994,77:1117.
3Kato T,Iwamatsu A ,Shimada Y ,et al, Purification and characterization of thrombopoietin derived from thrombocytopenic rat plasma. Blood, 1994,84 (Suppl 1 ) : 329a.
4Guraey MA,Scoble HA,Kum Y,et al. Structure characterization of natural human urinary and recombinat DNA-derived erythropoietin. J Bio Chem, 1987,226 : 17156.
5Chang M,Me.Ninch J,Basu R,et al. Cloning and characterazation of the human megakaryocyte growth and development factor (MGDF) gene. J Bio Chem, 1995,270: 511.
6Sungara R,Marbovic B,Chong Bh.et al. Localization and regulation of thrombopietin mRNA expression in human kidney.liver, bone marrow, and spleen using in situ hybridization.Blood. 1997,89 (1):101.
7Wendling F,Maraskovsky E,Debili N ,et al, C-mpl ligand is a humoral regulator of megakar yocytopoiesis. Nature, 1994,369:571.
8Koushansky K. Lok S, Holly RD, et al. Promotion of megakaryocyce progenitor expression and differantiation by the c-mpl ligand .thrombopoit in. Nature, 1994,369:586.
10Debili N, Wendling F. Katz A. et al. The mpl-ligand or thrombopoietin or megakaryocyte growth and differantiation factor has both proliferative and diferentiative activities on human megakaryocyte progeniters. Blood, 1995, 86 (7):2516.
